Systematic reviewindependent cross-checkabstract only checked I-GUT-09 standard review

Diet and multiple sclerosis (Cochrane)

Dietary interventions for multiple sclerosis-related outcomes.

Overview

Parks NE et al.. Cochrane Database Syst Rev 2020 · PMID 32428983 · DOI 10.1002/14651858.CD004192.pub4

No reliable evidence that diet changes relapses or disability in MS.

Does the study support the specific claim? No · Methodological quality: high

Study explained simply

What did the researchers want to find out?: Diet in MS.
How was the study done?: Cochrane review.
How many people, animals or samples were studied?: 30 trials.
What was actually found?: No clear effects.
How large was the observed effect?: RR ≈1.0.
What do the results mean in everyday life?: Diet cannot replace MS treatment.
What are the study's limitations?: Weak trials.
What does it say about Elawady's specific claim?: Contradicts C-AUTO-01.
Do the results apply to Germany and Europe?: Applicable.
What can explicitly not be concluded from this study?: Small benefits.

Authors: Parks NE et al.
Journal: Cochrane Database Syst Rev
Year: 2020
Identifier: PMID 32428983 DOI 10.1002/14651858.CD004192.pub4
Verification: verified – PubMed efetch 2026-10-25
Retracted: no
Corrections: none
Extent checked: abstract only
Conflicts of interest and funding: Natalie E Parks has provided consulting services to Biogen, EMD Serono, Roche, and Sanofi Genzyme. She has accepted funds from Biogen and Roche for travel to a scientific conference. She has acted as site sub‐investigator for clinical trials for Biogen, MedDay, Sanofi Genzyme, and Roche. She is the recipient of a Killam Predoctoral Scholarship, Nova Scotia Graduate Scholarship, and Dalhousie Medical Research Foundation Multiple Sclerosis Graduate Studentship. Caitlin S Jackson‐Tarlton: nothing to declare Laura Vacchi: nothing to declare Roah Merdad: nothing to declare Bradley C Johnston: As part of his recruitment to Texas A&M University, BCJ received a start‐up grant from Texas A&M AgriLife Research to fund investigator‐initiated research related to saturated and polyunsaturated fats. The grant was from Texas A&M AgriLife institutional funds from interest and investment earnings, not a sponsoring organization, industry, or company.

Effects of dietary interventions on MS outcomes

Study design: Systematic review – Cochrane systematic review of RCTs and CCTs
Population: Adults with MS
Country: Europe, North America, Middle East
Period: to May 2019
Sample size: 30 trials
Inclusion and exclusion criteria: RCT/CCT

Exposure / intervention: PUFAs, antioxidants, dietary programmes, other supplements
Comparator: Placebo/other
Endpoints: Relapse, disability, MRI, AEs
Statistical methods: GRADE

Results: PUFA vs MUFA relapse RR 1.02 (0.88–1.20, very low certainty); omega-3 vs omega-6 relapse RR 1.02; antioxidants relapse RR 0.98 (0.59–1.64); all trials had unknown or high risk of bias.
Absolute risks: not applicable
Authors' conclusion: Insufficient evidence that antioxidants or other dietary interventions affect MS outcomes.

High.

No evidence that diet controls MS.

Multidimensional assessment
Multidimensional assessment
Authenticity of the source	verified
Methodological quality	high
Risk of bias	low
Precision of results	low
Directness	direct
Reproducibility	unknown
Consistency with the overall evidence	unknown
Regional transferability	high
Adequacy of the interpretation (by the archive)	not applicable